147 related articles for article (PubMed ID: 31041552)
1. Assessment of Biopharmaceutical Performance of Supersaturating Formulations of Carbamazepine in Rats Using Physiologically Based Pharmacokinetic Modeling.
Thakore SD; Thakur PS; Shete G; Gangwal R; Narang AS; Sangamwar AT; Bansal AK
AAPS PharmSciTech; 2019 Apr; 20(5):179. PubMed ID: 31041552
[TBL] [Abstract][Full Text] [Related]
2. Investigating Oral Absorption of Carbamazepine in Pediatric Populations.
Kohlmann P; Stillhart C; Kuentz M; Parrott N
AAPS J; 2017 Nov; 19(6):1864-1877. PubMed ID: 28971365
[TBL] [Abstract][Full Text] [Related]
3. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
[TBL] [Abstract][Full Text] [Related]
4. Justification of biowaiver for carbamazepine, a low soluble high permeable compound, in solid dosage forms based on IVIVC and gastrointestinal simulation.
Kovacević I; Parojcić J; Homsek I; Tubić-Grozdanis M; Langguth P
Mol Pharm; 2009; 6(1):40-7. PubMed ID: 19248231
[TBL] [Abstract][Full Text] [Related]
5. In vivo brain microdialysis as a formulation-screening tool for a poorly soluble centrally acting drug.
Bommana MM; Kirthivasan B; Shikhar A; Gupta SS; Squillante E
Drug Dev Ind Pharm; 2014 Jan; 40(1):74-9. PubMed ID: 23298323
[TBL] [Abstract][Full Text] [Related]
6. Model-Based Analysis of Biopharmaceutic Experiments To Improve Mechanistic Oral Absorption Modeling: An Integrated in Vitro in Vivo Extrapolation Perspective Using Ketoconazole as a Model Drug.
Pathak SM; Ruff A; Kostewicz ES; Patel N; Turner DB; Jamei M
Mol Pharm; 2017 Dec; 14(12):4305-4320. PubMed ID: 28771009
[TBL] [Abstract][Full Text] [Related]
7. Prediction of oral absorption of cinnarizine--a highly supersaturating poorly soluble weak base with borderline permeability.
Berlin M; Przyklenk KH; Richtberg A; Baumann W; Dressman JB
Eur J Pharm Biopharm; 2014 Nov; 88(3):795-806. PubMed ID: 25195981
[TBL] [Abstract][Full Text] [Related]
8. Integration of Biorelevant Pediatric Dissolution Methodology into PBPK Modeling to Predict In Vivo Performance and Bioequivalence of Generic Drugs in Pediatric Populations: a Carbamazepine Case Study.
Pawar G; Wu F; Zhao L; Fang L; Burckart GJ; Feng K; Mousa YM; Al Shoyaib A; Jones MC; Batchelor HK
AAPS J; 2023 Jun; 25(4):67. PubMed ID: 37386339
[TBL] [Abstract][Full Text] [Related]
9. Role of humic acid on oral drug delivery of an antiepileptic drug.
Mirza MA; Agarwal SP; Rahman MA; Rauf A; Ahmad N; Alam A; Iqbal Z
Drug Dev Ind Pharm; 2011 Mar; 37(3):310-9. PubMed ID: 20815797
[TBL] [Abstract][Full Text] [Related]
10. A pH-dilution method for estimation of biorelevant drug solubility along the gastrointestinal tract: application to physiologically based pharmacokinetic modeling.
Gao Y; Carr RA; Spence JK; Wang WW; Turner TM; Lipari JM; Miller JM
Mol Pharm; 2010 Oct; 7(5):1516-26. PubMed ID: 20715778
[TBL] [Abstract][Full Text] [Related]
11. Discriminatory dissolution method for quality control measurements of carbamazepine immediate release tablets based on in vitro--in vivo investigations.
Xu C; Zou M; Wang Y; Liu Y; Yan J; Wu Y; Cheng G
Drug Dev Ind Pharm; 2012 Jun; 38(6):679-88. PubMed ID: 21988132
[TBL] [Abstract][Full Text] [Related]
12. Prediction of food effects on the absorption of celecoxib based on biorelevant dissolution testing coupled with physiologically based pharmacokinetic modeling.
Shono Y; Jantratid E; Janssen N; Kesisoglou F; Mao Y; Vertzoni M; Reppas C; Dressman JB
Eur J Pharm Biopharm; 2009 Sep; 73(1):107-14. PubMed ID: 19465123
[TBL] [Abstract][Full Text] [Related]
13. In Silico Modeling Approach for the Evaluation of Gastrointestinal Dissolution, Supersaturation, and Precipitation of Posaconazole.
Hens B; Pathak SM; Mitra A; Patel N; Liu B; Patel S; Jamei M; Brouwers J; Augustijns P; Turner DB
Mol Pharm; 2017 Dec; 14(12):4321-4333. PubMed ID: 28817288
[TBL] [Abstract][Full Text] [Related]
14. In vitro/in vivo correlations of dissolution data of carbamazepine immediate release tablets with pharmacokinetic data obtained in healthy volunteers.
Lake OA; Olling M; Barends DM
Eur J Pharm Biopharm; 1999 Jul; 48(1):13-9. PubMed ID: 10477323
[TBL] [Abstract][Full Text] [Related]
15. Evaluation and optimized selection of supersaturating drug delivery systems of posaconazole (BCS class 2b) in the gastrointestinal simulator (GIS): An in vitro-in silico-in vivo approach.
Hens B; Bermejo M; Tsume Y; Gonzalez-Alvarez I; Ruan H; Matsui K; Amidon GE; Cavanagh KL; Kuminek G; Benninghoff G; Fan J; Rodríguez-Hornedo N; Amidon GL
Eur J Pharm Sci; 2018 Mar; 115():258-269. PubMed ID: 29378253
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics, brain distribution and plasma protein binding of carbamazepine and nine derivatives: new set of data for predictive in silico ADME models.
Fortuna A; Alves G; Soares-da-Silva P; Falcão A
Epilepsy Res; 2013 Nov; 107(1-2):37-50. PubMed ID: 24050973
[TBL] [Abstract][Full Text] [Related]
17. Biopharmaceutical characterization of carbamazepine immediate release tablets. In vitro-in vivo comparison.
Homsek I; Parojcic J; Cvetkovic N; Popadic D; Djuric Z
Arzneimittelforschung; 2007; 57(8):511-6. PubMed ID: 17915636
[TBL] [Abstract][Full Text] [Related]
18. Forecasting in vivo oral absorption and food effect of micronized and nanosized aprepitant formulations in humans.
Shono Y; Jantratid E; Kesisoglou F; Reppas C; Dressman JB
Eur J Pharm Biopharm; 2010 Sep; 76(1):95-104. PubMed ID: 20576487
[TBL] [Abstract][Full Text] [Related]
19. Improved in vitro and in vivo performance of carbamazepine enabled by using a succinic acid cocrystal in a stable suspension formulation.
Ullah M; Shah MR; Bin Asad MHH; Hasan SMF; Hussain I
Pak J Pharm Sci; 2017 Nov; 30(6):2139-2145. PubMed ID: 29175782
[TBL] [Abstract][Full Text] [Related]
20. In vitro models for the prediction of in vivo performance of oral dosage forms.
Kostewicz ES; Abrahamsson B; Brewster M; Brouwers J; Butler J; Carlert S; Dickinson PA; Dressman J; Holm R; Klein S; Mann J; McAllister M; Minekus M; Muenster U; Müllertz A; Verwei M; Vertzoni M; Weitschies W; Augustijns P
Eur J Pharm Sci; 2014 Jun; 57():342-66. PubMed ID: 23988843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
